In this study we show that lower plasma kallikrein activity levels accompany more severe diabetic nephropathy and lower eGFR and that a genetic variant known to result in a higher plasma pre-kallikrein level is associated with higher eGFR. This evidence concerns the gene KLK4 and diabetic kidney disease.